About Ignite Proteomics Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., specializes in advanced RPPA technology for cancer diagnostics. As the only provider of a CLIA-accredited RPPA assay ...

Hundreds of millions of years ago, single cells joined forces to become multicellular organisms. At the foundation of this ...

When Steve Carr, senior director of the Proteomics Platform at the Broad Institute of MIT and Harvard, began working in ...

This infographic explores how a protein detection assay – which outperforms antibody-based proteomics approaches – can unlock ...

Nonalcoholic Fatty Liver Disease, or NAFLD, and nonalcoholic steatohepatitis (NASH) are becoming a global population health concern. Because diagnosing these diseases involves invasive liver biopsies, ...

Proteomics has become an essential area in medical research, propelled by the ability to quantitatively assess proteins on a ...

The global Proteomics Market is valued at an estimated USD 33.6 billion in 2024 and is projected to reach USD 60.5 billion by ...

Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global ...

Add articles to your saved list and come back to them any time. Proteomics International Laboratories has hired industry veteran Dr James Williams as a non-executive director in a boardroom boost ...

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the presentation to be provided by Dr Richard Lipscombe to at ...

By integrating multi-omics data, MILTON improves disease prediction and biomarker identification, advancing the field of ...